Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide for Obesity in Type 1 Diabetes
NCT07096908Phase 4Recruiting
- Sponsor
- Dasman Diabetes Institute
- Start
- Jul 2025
- Primary completion
- Feb 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in obesity, sponsored by Dasman Diabetes Institute. Started Jul 2025; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07096908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07096908.